SCHEMBL6203101

SCHEMBL6203101

Cc1ccc(Cc2cc3c(cc2Nc2ccccc2)[N]C(=O)N3)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
EGFR P00533 3/20 0.36
HPGD P15428 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
MAPT P10636 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
SRC P12931 2/20 0.35
PRKCD Q05655 2/20 0.35
RGS12 O14924 1/20 0.35
GMNN O75496 1/20 0.35
PRKD3 O94806 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PRKCG P05129 1/20 0.35
PRKCB P05771 1/20 0.35
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203291 0.92 EGFR (0.39) EGFRHPGDSMN1; SMN2MAPTMEN1
SCHEMBL6204330 0.89 CNR1 (0.39) EGFRHPGDSMN1; SMN2MAPTMEN1
SCHEMBL6204309 0.87 RAB9A (0.40) NPC1RAB9AEGFRHPGDSMN1; SMN2
SCHEMBL6204891 0.86 MAPT (0.38) EGFRSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL6205378 0.84 KMT2A (0.40) EGFRHPGDSMN1; SMN2MAPTMEN1
SCHEMBL6202957 0.84 ALDH1A1 (0.35) RAB9AEGFRHPGDSMN1; SMN2MAPT
SCHEMBL6206042 0.84 CYP3A4 (0.43) HPGDSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL6202823 0.84 EGFR (0.42) EGFRHPGDSMN1; SMN2MAPTMEN1
SCHEMBL6205452 0.82 EGFR (0.36) NPC1RAB9AEGFRHPGDSMN1; SMN2
SCHEMBL6202905 0.82 LTA4H (0.41) SMN1; SMN2MAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539708-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2005-06-15 EP disclosed
WO-2004024699-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2004-03-25 WO disclosed